BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1711125)

  • 1. Recombinant peripheral myelin protein P0 confers both adhesion and neurite outgrowth-promoting properties.
    Schneider-Schaulies J; von Brunn A; Schachner M
    J Neurosci Res; 1990 Nov; 27(3):286-97. PubMed ID: 1711125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of myelin P0 protein as a homophilic adhesion molecule.
    Filbin MT; Walsh FS; Trapp BD; Pizzey JA; Tennekoon GI
    Nature; 1990 Apr; 344(6269):871-2. PubMed ID: 1691824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P0 mRNA expression in cultures of Schwann cells and neurons that lack basal lamina and myelin.
    Brunden KR; Brown DT
    J Neurosci Res; 1990 Oct; 27(2):159-68. PubMed ID: 1701492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nr-CAM promotes neurite outgrowth from peripheral ganglia by a mechanism involving axonin-1 as a neuronal receptor.
    Lustig M; Sakurai T; Grumet M
    Dev Biol; 1999 May; 209(2):340-51. PubMed ID: 10328925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral myelin P0 protein mediates neurite outgrowth of cortical neurons in vitro and axonal regeneration in vivo.
    Yazaki T; Miura M; Asou H; Toya S; Uyemura K
    Neurosci Lett; 1994 Jul; 176(1):13-6. PubMed ID: 7526300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells.
    Menichella DM; Arroyo EJ; Awatramani R; Xu T; Baron P; Vallat JM; Balsamo J; Lilien J; Scarlato G; Kamholz J; Scherer SS; Shy ME
    Mol Cell Neurosci; 2001 Dec; 18(6):606-18. PubMed ID: 11749037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in demyelinating peripheral neuropathies support molecular model of myelin P0-glycoprotein extracellular domain.
    Kirschner DA; Saavedra RA
    J Neurosci Res; 1994 Sep; 39(1):63-9. PubMed ID: 7528817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin P0-protein, more than just a structural protein?
    Filbin MT; Tennekoon GI
    Bioessays; 1992 Aug; 14(8):541-7. PubMed ID: 1285424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schwann cells depleted of galactocerebroside express myelin-associated glycoprotein and initiate but do not continue the process of myelination.
    Owens GC; Bunge RP
    Glia; 1990; 3(2):118-24. PubMed ID: 1692007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A threshold effect of the major isoforms of NCAM on neurite outgrowth.
    Doherty P; Fruns M; Seaton P; Dickson G; Barton CH; Sears TA; Walsh FS
    Nature; 1990 Feb; 343(6257):464-6. PubMed ID: 2153939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L2/HNK-1 carbohydrate and protein-protein interactions mediate the homophilic binding of the neural adhesion molecule P0.
    Griffith LS; Schmitz B; Schachner M
    J Neurosci Res; 1992 Dec; 33(4):639-48. PubMed ID: 1282935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions.
    Hasse B; Bosse F; Hanenberg H; Müller HW
    Mol Cell Neurosci; 2004 Dec; 27(4):370-8. PubMed ID: 15555916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
    Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of monoclonal antibodies to the extracellular domain of P0.
    Archelos JJ; Roggenbuck K; Schneider-Schaulies J; Linington C; Toyka KV; Hartung HP
    J Neurosci Res; 1993 May; 35(1):46-53. PubMed ID: 7685397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice.
    Carenini S; Neuberg D; Schachner M; Suter U; Martini R
    Glia; 1999 Dec; 28(3):256-64. PubMed ID: 10559784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-bound CSPG mediates growth cone outgrowth and substrate specificity by Schwann cell contact with the DRG neuron cell body and not via growth cone contact.
    Castro C; Kuffler DP
    Exp Neurol; 2006 Jul; 200(1):19-25. PubMed ID: 16530184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtle roles of neural cell adhesion molecule and myelin-associated glycoprotein during Schwann cell spiralling in P0-deficient mice.
    Carenini S; Montag D; Schachner M; Martini R
    Glia; 1999 Sep; 27(3):203-12. PubMed ID: 10457367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased P0 glycoprotein gene expression in primary and transfected rat Schwann cells after treatment with axolemma-enriched fraction.
    Knight RM; Fossom LH; Neuberger TJ; Attema BL; Tennekoon G; Bharucha V; DeVries GH
    J Neurosci Res; 1993 May; 35(1):38-45. PubMed ID: 7685396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral motoneuron interactions with laminin and Schwann cell-derived neurite-promoting molecules: developmental regulation of laminin receptor function.
    Tomaselli KJ; Reichardt LF
    J Neurosci Res; 1988; 21(2-4):275-85. PubMed ID: 2975342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.